Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
NQO2 4835 MENADIONE CHEMBL590 TEND, DrugBank 12351651, 10433694, 15733542, 16765324, 15078100
NQO2 4835 CHEMBL490867 CHEMBL490867 DrugBank 10592235
NQO2 4835 RESVERATROL CHEMBL165 DrugBank 15350128, 15381063
NQO2 4835 CHEMBL389051 CHEMBL389051 DrugBank 10592235
NQO2 4835 TRETAZICAR CHEMBL23330 DrugBank 10592235
NQO2 4835 CASIMIROIN CHEMBL492762 DrugBank 10592235
NQO2 4835 CHEMBL1161866 CHEMBL1161866 DrugBank 16905546, 17031400
NQO2 4835 FLAVIN ADENINE DINUCLEOTIDE CHEMBL1232653 DrugBank 17139284, 17016423
NQO2 4835 CARICOTAMIDE CHEMBL2000716 TdgClinicalTrial
NQO2 4835 IODOMELATONIN CHEMBL289233 DrugBank 10592235
NQO2 4835 CYCLOPHOSPHAMIDE CHEMBL88 PharmGKB
NQO2 4835 MELATONIN CHEMBL45 DrugBank 19463840

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
NQO2 rs1143684 C cyclophosphamide efficacy no Allele C is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele T. 29938344 1449576854